decreased metastatic potential_Nbeal2<tm1a(EUCOMM)Wtsi>/Nbeal2<tm1a(EUCOMM)Wtsi>

http://metadb.riken.jp/0001273C57BL6NNbeal2tm1aEUCOMMWtsiWtsiNbeal2tm1aEUCOMMWtsiNbeal2tm1aEUCOMMWtsiNbeal2tm1aEUCOMMWtsi

decreased metastatic potential_Nbeal2<tm1a(EUCOMM)Wtsi>/Nbeal2<tm1a(EUCOMM)Wtsi>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• neurobeachin-like 2
  http://metadb.riken.jp/db/mgi_rdf/MGI:2448554

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Nbeal2<tm1a(EUCOMM)Wtsi>/Nbeal2<tm1a(EUCOMM)Wtsi>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Nbeal2<tm1a(EUCOMM)Wtsi>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• C57BL/6N-Nbeal2<tm1a(EUCOMM)Wtsi>/Wtsi

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• decreased metastatic potential
  http://purl.obolibrary.org/obo/MP_0001273

文献

http://purl.org/net/cito/citesAsAuthority

• Jose A. Guerrero, et.al., Gray platelet syndrome: proinflammatory megakaryocytes and α-granule loss cause myelofibrosis and confer metastasis resistance in mice., Blood, 2014, 124
  http://rdf.ncbi.nlm.nih.gov/pubmed/25258341